Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli Lilly ...

NEW YORK, NY - JANUARY 29: Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Pfizer PFE has seen a decline in revenues from its COVID-19 products, with a net ...

Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE)) stands against other undervalued defensive ...

Pfizer Inc. (NYSE:PFE) is included among the 12 Best Dividend Paying Stocks to Buy Now. Pfizer Inc. (NYSE:PFE) ranks among the world’s top pharmaceutical companies, with vast resources to back its ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or cancer is one of the most sought-after areas in the pharma/biotech space.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sprouts Farmers Market Inc (Symbol: SFM), where a total of 13,180 contracts have traded so ...

La voie semble désormais libre pour le rachat par Pfizer de la biotech américaine Metsera, spécialiste des traitements anti-obésité, ...

San Francisco — La voie semble désormais libre pour le rachat par Pfizer de la biotech américaine Metsera, spécialiste des ...